Your browser doesn't support javascript.
loading
Glucagon-like peptide-1 receptor activation stimulates PKA-mediated phosphorylation of Raptor and this contributes to the weight loss effect of liraglutide.
Le, Thao D V; Liu, Dianxin; Besing, Gai-Linn K; Raghavan, Ritika; Ellis, Blair J; Ceddia, Ryan P; Collins, Sheila; Ayala, Julio E.
Afiliação
  • Le TDV; Department of Molecular Physiology and Biophysics, Vanderbilt University School of Medicine, Nashville, United States.
  • Liu D; Department of Medicine, Vanderbilt University Medical Center, Nashville, United States.
  • Besing GK; Department of Molecular Physiology and Biophysics, Vanderbilt University School of Medicine, Nashville, United States.
  • Raghavan R; Department of Molecular Physiology and Biophysics, Vanderbilt University School of Medicine, Nashville, United States.
  • Ellis BJ; Department of Molecular Physiology and Biophysics, Vanderbilt University School of Medicine, Nashville, United States.
  • Ceddia RP; Department of Medicine, Vanderbilt University Medical Center, Nashville, United States.
  • Collins S; Department of Molecular Physiology and Biophysics, Vanderbilt University School of Medicine, Nashville, United States.
  • Ayala JE; Department of Medicine, Vanderbilt University Medical Center, Nashville, United States.
Elife ; 122023 Nov 06.
Article em En | MEDLINE | ID: mdl-37930356
The canonical target of the glucagon-like peptide-1 receptor (GLP-1R), Protein Kinase A (PKA), has been shown to stimulate mechanistic Target of Rapamycin Complex 1 (mTORC1) by phosphorylating the mTOR-regulating protein Raptor at Ser791 following ß-adrenergic stimulation. The objective of these studies is to test whether GLP-1R agonists similarly stimulate mTORC1 via PKA phosphorylation of Raptor at Ser791 and whether this contributes to the weight loss effect of the therapeutic GLP-1R agonist liraglutide. We measured phosphorylation of the mTORC1 signaling target ribosomal protein S6 in Chinese Hamster Ovary cells expressing GLP-1R (CHO-Glp1r) treated with liraglutide in combination with PKA inhibitors. We also assessed liraglutide-mediated phosphorylation of the PKA substrate RRXS*/T* motif in CHO-Glp1r cells expressing Myc-tagged wild-type (WT) Raptor or a PKA-resistant (Ser791Ala) Raptor mutant. Finally, we measured the body weight response to liraglutide in WT mice and mice with a targeted knock-in of PKA-resistant Ser791Ala Raptor. Liraglutide increased phosphorylation of S6 and the PKA motif in WT Raptor in a PKA-dependent manner but failed to stimulate phosphorylation of the PKA motif in Ser791Ala Raptor in CHO-Glp1r cells. Lean Ser791Ala Raptor knock-in mice were resistant to liraglutide-induced weight loss but not setmelanotide-induced (melanocortin-4 receptor-dependent) weight loss. Diet-induced obese Ser791Ala Raptor knock-in mice were not resistant to liraglutide-induced weight loss; however, there was weight-dependent variation such that there was a tendency for obese Ser791Ala Raptor knock-in mice of lower relative body weight to be resistant to liraglutide-induced weight loss compared to weight-matched controls. Together, these findings suggest that PKA-mediated phosphorylation of Raptor at Ser791 contributes to liraglutide-induced weight loss.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Redução de Peso / Liraglutida / Receptor do Peptídeo Semelhante ao Glucagon 1 / Proteína Regulatória Associada a mTOR Limite: Animals Idioma: En Revista: Elife Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Redução de Peso / Liraglutida / Receptor do Peptídeo Semelhante ao Glucagon 1 / Proteína Regulatória Associada a mTOR Limite: Animals Idioma: En Revista: Elife Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos